AI summary Trust: medium Third-party lab

LabG tested this tirzepatide batch (sep,14.2025) at 99.8% purity via HPLC. The tested quantity of 60.2mg showed a significant 20.4% deviation from the 50mg label, and endotoxin status is not available. The test is recent (3-6 months old). Customers can cross-check on the lab's public verification URL.

Watch out for
  • high quantity deviation
  • no endotoxin test
Test date
2025-12-29
Purity
99.80% 99.80%
Batch / lot
sep,14.2025
Lab
LabG
Quantity
label 50mg tested 60.2mg
Qty vs label
+20.4%
Endotoxins
n/a
Test score
6.7
Manufacturer
Shandong Aishi Biotechnology
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
50mg
Container
No Label / Silver Crimp / Red Cap
Catalogued
2026-04-16
Artifact hash
5a88cdc5785556d7…
This COA is part of TitrateLab's community-trust corpus. See more from Shandong Aishi Biotechnology or learn how trust scores are computed on the methodology page.